These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

38 related items for PubMed ID: 3585807

  • 1. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
    Evans DL, Nemeroff CB.
    J Psychiatr Res; 1987; 21(2):185-94. PubMed ID: 3585807
    [Abstract] [Full Text] [Related]

  • 2. Identifying subtypes of depression in clinician-annotated text: a retrospective cohort study.
    Kung B, Chiang M, Perera G, Pritchard M, Stewart R.
    Sci Rep; 2021 Nov 17; 11(1):22426. PubMed ID: 34789827
    [Abstract] [Full Text] [Related]

  • 3. "Clinical judgment" and the DSM-5 diagnosis of major depression.
    Maj M.
    World Psychiatry; 2013 Jun 17; 12(2):89-91. PubMed ID: 23737407
    [No Abstract] [Full Text] [Related]

  • 4. Cortisol and the Dexamethasone Suppression Test as a Biomarker for Melancholic Depression: A Narrative Review.
    Schumacher MM, Santambrogio J.
    J Pers Med; 2023 May 16; 13(5):. PubMed ID: 37241007
    [Abstract] [Full Text] [Related]

  • 5. Mental health and immunity (Review).
    Vasile C.
    Exp Ther Med; 2020 Dec 16; 20(6):211. PubMed ID: 33149775
    [Abstract] [Full Text] [Related]

  • 6. Hormonal Treatments for Major Depressive Disorder: State of the Art.
    Dwyer JB, Aftab A, Radhakrishnan R, Widge A, Rodriguez CI, Carpenter LL, Nemeroff CB, McDonald WM, Kalin NH, APA Council of Research Task Force on Novel Biomarkers and TreatmentsChild Study Center and Department of Radiology and Biomedical Imaging, Yale University, New Haven, Conn. (Dwyer); Department of Psychiatry, Case Western Reserve University, Cleveland, and Northcoast Behavioral Healthcare Hospital, Northfield, Ohio (Aftab); Yale School of Medicine, New Haven, Conn. (Radhakrishnan); Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis (Widge); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, Calif., and VA Palo Alto Health Care System, Palo Alto, Calif. (Rodriguez); Department of Psychiatry and Human Behavior, Butler Hospital, Brown University, Providence, R.I. (Carpenter); Department of Psychiatry, University of Texas at Austin (Nemeroff); Department of Psychiatry and Human Behavior, Emory University School of Medicine, Atlanta (McDonald); and Department of Psychiatry, University of Wisconsin-Madison (Kalin)..
    Am J Psychiatry; 2020 Aug 01; 177(8):686-705. PubMed ID: 32456504
    [Abstract] [Full Text] [Related]

  • 7. Impact of sex and depressed mood on the central regulation of cardiac autonomic function.
    Garcia RG, Mareckova K, Holsen LM, Cohen JE, Whitfield-Gabrieli S, Napadow V, Barbieri R, Goldstein JM.
    Neuropsychopharmacology; 2020 Jul 01; 45(8):1280-1288. PubMed ID: 32152473
    [Abstract] [Full Text] [Related]

  • 8. Fetal hormonal programming of sex differences in depression: linking women's mental health with sex differences in the brain across the lifespan.
    Goldstein JM, Holsen L, Handa R, Tobet S.
    Front Neurosci; 2014 Jul 01; 8():247. PubMed ID: 25249929
    [No Abstract] [Full Text] [Related]

  • 9. Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.
    Goldstein JM, Handa RJ, Tobet SA.
    Front Neuroendocrinol; 2014 Jan 01; 35(1):140-58. PubMed ID: 24355523
    [Abstract] [Full Text] [Related]

  • 10. Cognitive factors and classification issues in adolescent depression.
    Craighead WE.
    J Youth Adolesc; 1991 Apr 01; 20(2):311-26. PubMed ID: 24265012
    [Abstract] [Full Text] [Related]

  • 11. Immune suppression and immune activation in depression.
    Blume J, Douglas SD, Evans DL.
    Brain Behav Immun; 2011 Feb 01; 25(2):221-9. PubMed ID: 20955778
    [Abstract] [Full Text] [Related]

  • 12. HPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings.
    Coryell W, Fiedorowicz J, Zimmerman M, Young E.
    Psychoneuroendocrinology; 2008 Jun 01; 33(5):654-8. PubMed ID: 18378097
    [Abstract] [Full Text] [Related]

  • 13. Corticosterone levels determine individual vulnerability to amphetamine self-administration.
    Piazza PV, Maccari S, Deminière JM, Le Moal M, Mormède P, Simon H.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2088-92. PubMed ID: 2006148
    [Abstract] [Full Text] [Related]

  • 14. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
    Evans DL, Nemeroff CB.
    J Psychiatr Res; 1987 Mar 15; 21(2):185-94. PubMed ID: 3585807
    [Abstract] [Full Text] [Related]

  • 15. The dexamethasone suppression test in the clinical setting.
    Evans DL, Burnett GB, Nemeroff CB.
    Am J Psychiatry; 1983 May 15; 140(5):586-9. PubMed ID: 6342422
    [Abstract] [Full Text] [Related]

  • 16. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M, De Ruyter M, Suy E.
    Psychoneuroendocrinology; 1989 May 15; 14(3):231-9. PubMed ID: 2756075
    [Abstract] [Full Text] [Related]

  • 17. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
    Evans DL, Nemeroff CB, Haggerty JJ, Pedersen CA.
    Psychoneuroendocrinology; 1987 May 15; 12(3):203-9. PubMed ID: 3615749
    [Abstract] [Full Text] [Related]

  • 18. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H, Sarai M.
    Seishin Shinkeigaku Zasshi; 2000 May 15; 102(4):367-98. PubMed ID: 10892305
    [Abstract] [Full Text] [Related]

  • 19. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR, Weissenburger JE, Crowley GT, Khatami M, Vasavada N.
    J Clin Psychiatry; 1996 Oct 15; 57(10):470-84. PubMed ID: 8909334
    [Abstract] [Full Text] [Related]

  • 20. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
    Evans DL, Nemeroff CB.
    J Psychiatr Res; 1987 Oct 15; 21(2):185-94. PubMed ID: 3585807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.